Our platform is built around three ecosystems: Medical Innovation, Private Equity and Critical Resources. Each is, at any given time, our current focus: the projects we are actively working on.
Connecting Swiss innovation with US healthcare markets, backed by a deep network of research institutions and clinical partners.
Fund selection and strategic co-investments, giving institutional partners access to a curated set of leading managers.
Strategic mining and energy transition opportunities, positioned at the intersection of resource security and the global energy transition.
Across all three ecosystems, we concentrate on the most resilient elements: the projects, teams and structures best positioned to withstand cycles and compound value over the long term.
Our platform targets resilient, high-potential investments, deployed with private-equity discipline, whether the company is private or listed. What we build for our own account is what we propose to our partners: our platform is our current focus, and our current focus is the projects we are working on today.
Each of our three strategies is managed independently but shares the same underlying discipline: rigorous selection, direct relationships with entrepreneurs and managers, and a long-term view on value creation.
Rather than spreading capital broadly, we concentrate our attention on a small number of opportunities where we can add genuine strategic value beyond capital alone.
We combine entrepreneurial experience, specialist expertise and investment discipline to make better decisions throughout the life of a company.
We have been entrepreneurs ourselves.
We have already faced most situations before.
We invest alongside our partners: real capital, not fees dressed up as commitment.
We propose to investors exactly what we do for ourselves.
Success comes from making the right decisions at the right time.
Entrepreneurs succeed with the best specialists, not by knowing everything.
We challenge assumptions and open new strategic paths.
We remain alongside our investments and can continue supporting them when it matters most.
Explore the Medical Innovation platform currently under active development.
See Current Focus